Barclays analyst Julian Mitchell raised the firm’s price target on Ametek (AME) to $220 from $210 and keeps an Equal Weight rating on the shares. The firm is “curious” to see how the company will use acquisitions to augment its organic growth.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AME:
- Resilient Revenue and Margin Caution Keep Ametek at Hold
- AMETEK (AME) Earnings Call Highlights Record Year
- Ametek: Robust End Markets, Improving Growth Momentum, and Ample Capital Firepower Underpin Buy Rating and Higher $260 Target
- AMETEK Delivers Record 2025 Results and Confident 2026 Outlook
- Ametek buys LKC Technologies from DW Healthcare